TCBPW
TC BioPharm (Holdings) plc WarrantsTCBPW
TCBPW
Delisted
TCBPW was delisted on the 21st of March, 2025.
About: TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
Employees: 41
Charts implemented using Lightweight Charts™